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SUMMARY
Introduction: Leishmaniasis is classified into three clinical presentations: visceral, coetaneous and mucocutaneous. The latter
is usually secondary to hematogenous spread after months or years of skin infection and can manifest as infiltrative lesions,
ulcerated or vegetating in nose, pharynx, larynx and mouth, associated or not with ganglionics infarction. Laryngeal involvement
is part of the differential diagnosis of lesions in this topography as nonspecific chronic laryngitis, granulomatosis and even
tumors of the upper aerodigestive tract presenting atypical evolution. Sometimes it is difficult for the correct diagnosis of
Leishmaniasis, with description of cases in the literature were conducted improperly.
Objective: The objective of this study is to report a case of laryngeal Leishmaniasis addressing the difficulty of diagnosis,
complications and treatment applied.
Case Report: A patient with pain throat, dysphagia, odynophagia, dysphonia and weight loss, with no improvement with
symptomatic medication. At telelaringoscopy, infiltrative lesion showed nodular supraglottis. He underwent a tracheotomy for
airway obstruction and biopsy with immunohistochemical study for a definitive diagnosis of laryngeal Leishmaniasis. The
patient was referred to the infectious diseases that initiated treatment with N-methylglucamine antimoniate with satisfactory
response to therapy.
Final Comments: Faced with a clinical suspicion of granulomatous diseases, it is essential to follow protocol laboratory
evaluation associated with histological injury, to get a precise definition etiological without prolonging the time of diagnosis.
Medical treatment for mucosal Leishmaniasis, recommended by the World Health Organization, was adequate in the case of
laryngeal disorders, with complete resolution of symptoms.
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INTRODUCTION
Leishmaniasis is an infectious granulomatous
disease; non-contagious disease caused by protozoan
species Leishmania brasiliensis, L. amazonensis, L.
panamensis and Leishmania guyanensis, typically found
in the Americas. Its transmission occurs through the bite
of sandflies insects, whose genre most often found in
Brazil is Lutzomya. Over the past 20 years, the occurrence
of this disease is growing rapidly, both in magnitude
and geographical expansion, with outbreaks in various
regions of the country and, more recently, in the
Amazon area, related to the predatory process of
colonization (1).
Traditionally, the disease is classified into three
clinical presentations: visceral (Kala-azar), coetaneous
and mucocutaneous. The latter is usually secondary to
hematogenous spread after months or years of skin
infection and can manifest as infiltrative lesions,
ulcerated or vegetating in nose (most common site),
pharynx, larynx and mouth, bloating associated or not
with lymph node (2). The involvement of mucosa is
dependent on the combination of virulence of the
parasite and cellular host immune response. Among
the population of infected individuals, 1 to 10% occurs
with mucosal involvement; however, the specific factors
that will determine which patients will develop the
mucocutaneous Leishmaniasis are still not well
understood (3).
524
Int. Arch. Otorhinolaryngol., São Paulo - Brazil, v.16, n.4, p. 523-526, October / November / Dezember - 2012.
Low prevalence, laryngeal involvement
Leishmaniasis is part of the differential diagnosis of
lesions in this topography as nonspecific chronic
laryngitis, and even granulomatosis of upper
aerodigestive tract tumors that exhibit atypical evolution
(4, 5). Sometimes it is difficult for the correct diagnosis
of Leishmaniasis, with description of cases in the
literature were conducted initially as malignancy,
including undergoing radiotherapy, with subsequent
confirmation of infectious etiology (6).
The objective of this study is to report a case of
laryngeal Leishmaniasis addressing their diagnostic difficulty,
complications and treatment applied.
CASE REPORT
SJS patient, male, 51 years old, black, mason, born
in União dos Palmares - AL, and living in Sao Paulo - SP, was
treated at the Otolaryngology department of a tertiary
hospital in São Paulo, with reports of “sore throat” there
three years, which has evolved over the past four months
with dysphagia, odynophagia, dysphonia and weight loss
of about 8 pounds in this period, no improvement with
symptomatic medication. He denied fever, ear or respiratory
complaints. Smoking history presented as moderate, severe
alcoholics without a history of hypertension, diabetes
mellitus or infectious diseases.
On physical examination, with regular general
condition, without significant changes in the respiratory,
cardiovascular or abdomen. At telelaringoscopy, nodular
infiltrative lesion was visualized in supraglottis involving
the epiglottis, aryepiglottic, looking vegetating in left
piriformis sinus and arytenoids edema. The vocal folds
were mobile and without structural lesions with complete
glottal closure (Figure 1).
Preoperative tests were ordered, then the patient
underwent suspension laryngoscopy with biopsy of the
lesion and the histopathology revealed the case of an
ulcerated inflammatory process.
Three weeks after this biopsy, the patient developed
dyspnea and worsening of dysphagia, accepting only
pasty-liquid diet. Tracheotomy was performed and new
biopsy showed that the atypical lymphoid infiltration
histopathology. The piece was sent to perform
immunohistochemistry to detect amastigote of Leishmania
sp. in the sample.
The patient was referred to the infectious diseases
that initiated treatment with N-methylglucamine
antimoniate at a dose of 20mg/kg/day, intramuscularly, for
30 days with outpatient and uneventful. There was
significant improvement of the table early in the treatment,
control laryngoscopy after the 30th day showed resolution
of the lesions. Then, the tracheotomy was performed
decannulation (Figure 2).
Three months after treatment, the patient
presented with significant improvement of his general
condition and nutritional asymptomatic and in their
professional activities.
DISCUSS
Leishmaniasis is rarely detected early on. The
patient usually presents one or few skin lesions, which
appear three to ten weeks after inoculation, with a
tendency to spontaneous healing in a few months, even
without treatment. In some cases the lesions remain
active for several years and it is estimated that 3 to 5%
may develop with subsequent emergence of mucosal
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Figure 1. Laryngoscopy Pretreatment.
Figure 2. Laryngoscopy Post-treatment.
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lesions by hematogenous spread. In the case reported the
presentation was mucosa of unknown origin, since there
was no coetaneous lesion. It is believed that such would
probably be associated with subclinical infections or
minor injuries, non-ulcerated, with rapid evolution and
that would have gone unnoticed without noticeable
scarring (1).
Pharyngolaryngeal involvement can be intense
enough to cause dysphagia, dyspnea, dysphonia, sore
throat and cough. A peculiarity of this case differs from that
literature is the absence of nasal lesions which are often
found in the initial shape of the mucosal Leishmaniasis.
Even this is a parameter used in the differential diagnosis
of diseases such as tuberculosis and laryngeal
Paracoccidioidomycosis who rarely have associated nasal
lesions (7).
The laryngoscopy usually demonstrates an extensive
inflammatory component, with erythema and edema
evident. The granulomatous associated ulcers are common
and may also submit purulent exudates. In advanced
disease, tissue destruction may be striking. Before this
presentation, it is important hypotheses of other diseases
as leprosy, sarcoidosis, syphilis, Wegner granulomatosis,
systemic lupus erythematosus actinomycosis, Histoplasmosis
and neoplasm (8, 9).
By presenting a more gorgeous, both in terms of
symptomatology and the findings of laryngoscopy, the
patient was referred initially reported to the laryngeal
lesion biopsy in an attempt to elucidate the diagnosis,
rather than a complement careful laboratory evaluation.
Given that the diagnosis of Leishmaniasis can be determined
by parasitological examinations (direct search or culture),
immunological tests (intradermal of Montenegro) or
molecular tests (polymerase chain reaction), solving this
case likely would have been anticipated if they were
requested Routine tests for suspected cases of
granulomatosis (VDRL, Montenegro reaction, PPD, serology
for Histoplasmosis and Paracoccidioidomycosis, chest
radiography). Especially because the cases of mucosal
Leishmaniasis usually have strong positive intradermal of
Montenegro, and secondly parasitological confirmation
difficult due to the shortage parasite, which was evident by
the need for two biopsies and complementation analysis
with immunohistochemistry for the identification of
amastigote (1) . Therefore, as research protocol for
suspected etiologic granulomatosis in organs such as the
larynx difficult access, should initially be requested laboratory
tests and imaging, and case stay uncertain diagnosis, biopsy
is indicated for the histological lesions. If the appearance of
the lesion suggests malignancy, research through
noninvasive tests and invasive must occur simultaneously
to avoid delay diagnosis.
In the case of infectious diseases with risk of
contamination, the diagnosis should be established as
soon as possible. The interval between onset of
symptoms and diagnosis in a way reflects the ease of
access to health services as well as efficiency in
diagnosis.
The regimen used was satisfactory. The same is in
accordance with the recommendations of the World Health
Organization (WHO), which recommends N-
methylglucamine antimoniate as first choice at a dose of
20mg/kg/day lasting at least 30 days. In patients with
contraindications (pregnancy due to teratogenicity) or
refractory to standard treatment, should be used amphotericin
B (10).
FINAL COMMENTS
Before clinical suspicion with granulomatous diseases,
it is vital following protocol associated with laboratory
evaluation of histological injury to achieve a precise definition
etiological without prolonging the time of diagnosis. Medical
treatment for mucosal Leishmaniasis, recommended by
WHO, was adequate in the case of laryngeal disorders, with
complete resolution of symptoms.
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